Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Patients with coronary artery disease or heart failure have been shown to be insulin resistant.Whether in these patients heart muscle participates in the insulin resistance, and whether reduced blood flow is a mechanism for such resistance is not known.We measured heart and skeletal muscle blood flow and glucose uptake during euglycemic hyperinsulinemia (insulin clamp) in 15 male patients with angiographically proven coronary artery disease and chronic regional wall motion abnormalities.Six age-and weightmatched healthy subjects served as controls.Regional glucose uptake was measured by positron emission tomography using [ 18 F]2-fluoro-2-deoxy-D -glucose (FDG), blood flow was measured by the H 2 15 O method.Myocardial glucose utilization was measured in regions with normal perfusion and wall motion as assessed by radionuclide ventriculography.Whole-body glucose uptake was 37 Ϯ 4 mol и min Ϫ 1 и kg Ϫ 1 in controls and 14 Ϯ 2 mol и min Ϫ 1 и kg Ϫ 1 in patients ( P ϭ 0.001).Myocardial blood flow (1.09 Ϯ 0.06 vs. 0.97 Ϯ 0.04 ml и min Ϫ 1 и g Ϫ 1 , controls vs. patients) and skeletal muscle (arm) blood flow (0.046 Ϯ 0.012 vs. 0.043 Ϯ 0.006 ml и min Ϫ 1 и g Ϫ 1 ) were similar in the two groups ( P ϭ NS for both).In contrast, in patients both myocardial (0.38 Ϯ 0.03 vs. 0.70 Ϯ 0.03 mol и min Ϫ 1 и g Ϫ 1 , P ϭ 0.0005) and muscle glucose uptake (0.026 Ϯ 0.004 vs. 0.056 Ϯ 0.006 mol и min Ϫ 1 и g Ϫ 1 , P ϭ 0.005) were markedly reduced in comparison with controls.In the whole dataset, a direct relationship existed between insulin-stimulated glucose uptake in heart and skeletal muscle.Patients with a history of myocardial infarction and a low ejection fraction are insulin resistant.This insulin resistance affects both the myocardium and skeletal muscle and is independent of blood flow.( J. Clin.Invest.1996.98:2094-2099.)Key words: insulin resistance • coronary heart disease • skeletal muscle • myocardial muscle 15 O).Euglycemic hyperinsulinemia measures whole-body insulin resistance and enhances the FDG signal during PET (14).The model chosen was the noninfarcted myocardium of patients who have suffered from an acute myocardial infarction. Methods Patients.The patient population consisted of 15 normotensive, nondiabetic men (aged 54 Ϯ 2 years, range 34-62) with coronary artery disease.All patients had suffered a previous myocardial infarction at least 6 mo before the study.All patients had at least one ventricular
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“Norepinephrine can increase free fatty acid (FFA) levels (52), and FFA in turn can decrease glucose utilization both in heart (5) and skeletal muscle (53) by substrate competition (54).”
BackgroundContribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM
Mitrakou, A., Kelley, D., Veneman, T., Jenssen, T., Pangburn, T., Reilly, J., & Gerich, J. (1990) · Diabetes · doi:10.2337/diab.39.11.1381 · Cited by 317
Kelley, D. E., & Mandarino, L. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114935 · Cited by 210 · cited 1×
“Thus, the arm skeletal muscle blood flow rates measured by PET in the present study are in the range of those measured in the forearm of healthy subjects during a euglycemic clamp with the use of an indicator dilution method (30) or by venous occlusion plethysmography (31).”
Method
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ferrannini, E., Mark, M., & Mayoux, E. (2016) · Diabetes Care · doi:10.2337/dc16-0330 · Cited by 975
“However, in patients with T2D (27,46) as well as in patients without diabetes with coronary artery disease (47) or stress-induced ischemia (48), whole-body and myocardial insulin-mediated glucose utilization are impaired (i.”
BackgroundSelf-citationDeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Metabolic remodelling in heart failure
Bertero, E., & Maack, C. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0044-6 · Cited by 706
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Metadata
- Authors
- Paternostro, G., Camici, P. G., Lammerstma, A. A., Marinho, N., Baliga, R. R., Kooner, J. S., Radda, G. K., & Ferrannini, E.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-11-01
- Volume
- 98
- Issue
- 9
- Pages
- 2094-2099
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2036515253
- Cited by
- 150
- References
- 3
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. https://app.cochat.ai/papers/10.1172/jci119015
- The paper
- Paternostro, G., Camici, P. G., Lammerstma, A. A., Marinho, N., Baliga, R. R., Kooner, J. S., Radda, G. K., & Ferrannini, E. (1996). Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. Journal of Clinical Investigation. https://doi.org/10.1172/jci119015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.